2/23/2010

Bioscience Vaccines will receive an investment of $400,000 from the Indiana Seed Fund, which was set up by BioCrossroads to help life sciences firms. Bioscience plans to put the money toward a technology that can be used to develop adjuvants, which can boost the efficacy of vaccines.

Related Summaries